pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

8,462 catalysts · 6,181 phase readout · 2,275 8k filing · 390 earnings · 3 pdufa · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 0 catalysts2026-08-11: 0 catalysts2026-08-12: 0 catalysts2026-08-13: 0 catalysts2026-08-14: 4 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 3 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type
  • phase readout6,181
  • 8k filing2,275
  • earnings390
  • pdufa3
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

12
›RECRUITINGphase readoutNCT06474273: TACKLE-IT Trial - Treat Acute T Cell Rejection With Evidence and Confidence in Kidney Transplant Recipients

Sponsor: University of Sydney. Phase: PHASE3. Conditions: Rejection; Transplant, Kidney, Rejection; Transplant, Pancreas

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04234373: Effect of a Low-carb Dietary Intervention in Obese Patients: a Pilot Trial

Sponsor: University Hospital, Basel, Switzerland. Phase: NA. Conditions: Glucose Intolerance, Obesity

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07362173: Actualities in Procedural Sedation: Remimazolam

Sponsor: Iuliu Hatieganu University of Medicine and Pharmacy. Phase: PHASE4. Conditions: ASA Class III/IV Patients, COPD III/IV, Age 65 and Older, Multiple Organ Failure

full page →ctgov ↗
›COMPLETEDphase readoutNCT07548073: Effect of Scene-Based Training on Cognitive Function in Patients With Alzheimer's Disease

Sponsor: Zhejiang Provincial Tongde Hospital. Phase: NA. Conditions: Alzheimer Disease, Cognitive Dysfunction, Mild Cognitive Impairment

full page →ctgov ↗
›COMPLETEDphase readoutNCT01892189: Effects of TAK-063 on Preventing Ketamine-Induced Brain Activity Changes as Well as Psychotic-Like Symptoms in Healthy Male Adults

Sponsor: Takeda. Phase: PHASE1. Conditions: Ketamine-Induced Brain Activity Changes, Psychotic-like Symptoms

full page →ctgov ↗
›RECRUITINGphase readoutNCT06696768: Clinical Trial of an Anti-cancer Drug, CA-4948 (Emavusertib), in Combination With Chemotherapy Treatment (FOLFOX Plus Bevacizumab) in Metastatic Colorectal Cancer

Sponsor: National Cancer Institute (NCI). Phase: PHASE1. Conditions: Metastatic Colorectal Adenocarcinoma, Stage III Colorectal Cancer AJCC v8, Stage IV Colorectal Cancer AJCC v8, Unresectable Colorectal Adenocarcinoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT03053791: Deep Brain Stimulation in Patients With Incomplete Spinal Cord Injury for Improvement of Gait

Sponsor: University of Zurich. Phase: NA. Conditions: Spinal Cord Injury

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07475091: Standardizing Swallow Pressure Measurements

Sponsor: University of Wisconsin, Madison. Phase: NA. Conditions: Dysphagia

full page →ctgov ↗
›COMPLETEDphase readoutNCT04932291: Study to Test the Efficacy and Safety of Vafidemstat in Adult Borderline Personality Disorder Population

Sponsor: Oryzon Genomics S.A.. Phase: PHASE2. Conditions: Borderline Personality Disorder

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06334991: Study for Participants With Relapsed/Refractory Non-Hodgkin Lymphoma

Sponsor: ImmunityBio, Inc.. Phase: PHASE1. Conditions: Non-Hodgkin Lymphoma Refractory/ Relapsed

full page →ctgov ↗
›RECRUITINGphase readoutNCT06175091: Impact of an Alarm Management Protocol on Noise Pollution and Patient Safety in Intensive Care Units

Sponsor: Centre Hospitalier Universitaire de Saint Etienne. Phase: NA. Conditions: Intensive Care Unit

full page →ctgov ↗
›COMPLETEDphase readoutNCT01563874: Proteomic-Based Profiling of Lymphomas: Chromatin Proteomics; Composition and Modification of Histone and Non-Histone Chromosomal Proteins

Sponsor: National Cancer Institute (NCI). Phase: . Conditions: Lymphoma, Lymphoid Hyperplasia

full page →ctgov ↗
← prev
page 170 of 170
next →